Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-07-17

Clinical Trial Update: S-Equol in Alzheimer's Disease 2 Trial [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating S-equol for Alzheimer's disease has completed, with results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • S-Equol (S-equol)

Snippet

Sponsor: Russell Swerdlow | Conditions: Alzheimer Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-07-17